Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more affordable
Their approach includes scheduled lab work, heart health evaluations, and ongoing clinical support for patients using medications such as semaglutide, tirzepatide, Mounjaro, Wegovy, and Ozempic
all should be discontinued when pregnancy is recognized) [1] [4] After prolonged treatment interruptions (typically 2 consecutive missed doses or longer gaps), re-titration from the initial dose may be necessary according to product-specific guidelines to minimize gastrointestinal side effects
Sarwer, PhD, director of the Center for Obesity Research and Education, Temple University, and a spokesperson for the Obesity Society who wasnt involved in the research
Long-term efficacy of liraglutide in Indian patients with type 2 diabetes in a real-world setting